Matthew T. Wiley Vyne Therapeutics Inc. (VYNE) insider trading activity

Matthew T. Wiley is Chief Commercial Officer of VYNE Therapeutics Inc.. Currently has a direct ownership of 109,246 shares of VYNE, which is worth approximately $211,937. The most recent transaction as insider was on Jun 30, 2021, when has been sold 5,151 shares (Common Stock) at a price of $3.51 per share, resulting in proceeds of $18,080. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K

0% 3M change

0% 12M change

Total Value Held $211,937

Matthew T. Wiley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2021	SELL Payment of exercise price or tax liability	$18,080 $3.51 p/Share	5,151 Reduced 4.5%	109,246 Common Stock
Mar 31 2021	SELL Payment of exercise price or tax liability	$17,599 $6.84 p/Share	2,573 Reduced 2.2%	114,397 Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	27,675 Added 19.13%	116,970 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$2,435 $1.58 p/Share	1,541 Reduced 0.43%	357,181 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$11,365 $1.45 p/Share	7,838 Added 2.14%	358,722 Common Stock
Sep 30 2020	SELL Payment of exercise price or tax liability	$2,558 $1.66 p/Share	1,541 Reduced 0.44%	350,884 Common Stock

Also insider at

BTAI

BioXcel Therapeutics, Inc. Healthcare

Chief Commercial Officer

MTW

Matthew T. Wiley

Chief Commercial Officer

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Vyne Therapeutics Inc. insider buys or sells VYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to VYNE Therapeutics Inc.

Track Activities on VYNE

Account